PDMR share purchase

RNS Number : 1254W

IXICO plc

09 December 2019

 

9 December 2019

IXICO plc

("IXICO" or the "Company")

PDMR share purchase

IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, announces that it received notification on 6 December 2019 that on 5 December 2019 John Hall, SVP Corporate Development and a PDMR, sold 100,000 ordinary shares at an aggregated price of 68.00p.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	John James Hall
2	Reason for the notification
a)	Position/status	PDMR (SVP Corporate Development)
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	IXICO plc
b)	LEI	2138005M1F59O6HWSA97
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares in IXICO plc
	Identification code	GB00BCLY7L40
b)	Nature of the transaction	Sale
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			68p	100,000
d)	Aggregated information
	- Aggregated volume	100,000 shares
	- Price	68p
e)	Date of the transaction	5/12/19
f)	Place of the transaction	London Stock Exchange, AIM Market (IXI), UK

IXICO plc	[phone]
Giulio Cerroni, Chief Executive Officer
Grant Nash, Chief Financial Officer
Cenkos Securities PLC (Nominated adviser and sole broker)	[phone]
Giles Balleny / Max Gould (Corporate Finance)
Michael F Johnson / Russell Kerr (Sales)
Optimum Strategic Communications	[phone]
Mary Clark / Anne Marieke Ezendam / Supriya Mathur
[e-mail]

 

END

 

 

DSHUGGUCPUPBPGR